Benzinga's Top Upgrades, Downgrades For December 28, 2016

Top Upgrades

• Analysts at Raymond James upgraded Bank of New York Mellon Corp BK from Outperform to Strong Buy. The price target for Bank of New York Mellon has been raised from $50 to $57. Bank of New York Mellon shares rose 0.32 percent to close at $47.73 on Tuesday.

Top Downgrades

• Barrington Research downgraded Franklin Covey Co. FC from Outperform to Market Perform. Franklin Covey shares rose 0.48 percent to close at $20.85 on Tuesday.

Top Initiations

• Analysts at H.C. Wainwright initiated coverage on Ocera Therapeutics Inc OCRX with a Buy rating. The price target for Ocera Therapeutics is set to $10. Ocera Therapeutics shares closed at $2.20 on Tuesday.
• Analysts at Janney Capital initiated coverage on Impax Laboratories Inc IPXL with a Neutral rating. The price target for Impax Laboratories is set to $15. Impax Laboratories shares closed at $13.25 on Tuesday.